ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,870.62
      -1.32%
      US Tech 100
      19,880.00
      -2.30%
      Dow Jones
      43,444.99
      -0.70%
      Brent Oil
      70.895
      0.00%
      Bitcoin
      91,520.03
      0.50%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. CureVac NV (CVAC) Quote

      CureVac NV

      CureVac NV (CVAC)

      NASDAQ
      2.54
      -0.13
      (-4.87%)
      Closed November 16 4:00PM
      Delayed by 15 minutes
      2.51
      -0.03
      (-1.18%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      2.54
      Bid
      2.02
      Ask
      4.90
      Volume
      1,102,613
      2.50 Day's Range 2.675
      2.215 52 Week Range 6.30
      Market Cap
      568.931M
      Previous Close
      2.67
      Open
      2.66
      Last Trade
      10
      @
      2.59
      Last Trade Time
      Financial Volume
      $ 2,819,482
      VWAP
      2.5571
      Average Volume (3m)
      452,835
      Shares Outstanding
      223,988,675
      Dividend Yield
      -
      PE Ratio
      -2.19
      Earnings Per Share (EPS)
      -1.16
      Revenue
      61.71M
      Net Profit
      -260.17M

      About CureVac NV

      CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-gen... CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-generation COVID-19 vaccine. CureVac's first attempt to develop a COVID-19 vaccine did not have sufficient efficacy data, and its trials were discontinued in October 2021. The company's other pipeline candidates include mRNA vaccines for influenza, rabies, and malaria. Additionally, CureVac is in the early stages of development for oncology and molecular therapies spanning tumors, liver, ocular, and lung diseases. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.curevac.com
      Headquarters
      Tubingen, Deu
      Founded
      -
      CureVac NV is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CVAC. The last closing price for CureVac NV was $2.67. Over the last year, CureVac NV shares have traded in a share price range of $ 2.215 to $ 6.30.

      CureVac NV currently has 223,988,675 shares outstanding. The market capitalization of CureVac NV is $598.05 million. CureVac NV has a price to earnings ratio (PE ratio) of -2.19.

      Ask ADVFN Intelligence (AI)

      CVAC Latest News

      More News

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      November 12 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      November 12 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      November 04 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      November 04 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      September 27 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      September 25 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      September 13 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      September 12 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      September 09 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      August 15 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.28-9.929078014182.822.972.516595772.78264619CS
      4-0.29-10.24734982332.833.032.514924132.79286826CS
      12-0.68-21.11801242243.223.442.514528352.95747658CS
      26-0.59-18.84984025563.135.282.518937533.52061305CS
      52-3.13-55.20282186955.676.32.2159236383.66086237CS
      156-34.07-93.062004916736.6150.092.2157294629.59542964CS
      260-82.45-97.011413107484.991332.21579741833.64902934CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CEROCERo Therapeutics Holdings Inc
      $ 0.2853
      (52.40%)
      		1.17B
      CYCNCyclerion Therapeutics Inc
      $ 2.5306
      (42.97%)
      		11.99M
      SPPLSIMPPLE Ltd
      $ 1.2503
      (41.60%)
      		165.69M
      PULMPulmatrix Inc
      $ 6.5586
      (39.54%)
      		5.37M
      ZTEKZentek Ltd
      $ 1.2574
      (29.96%)
      		309.67k
      TFFPTFF Pharmaceuticals Inc
      $ 0.376101
      (-76.49%)
      		9.23M
      EYENEyenovia Inc
      $ 0.10185
      (-70.05%)
      		51.98M
      CTXRCitius Pharmaceuticals Inc
      $ 0.1974
      (-39.89%)
      		11.15M
      VVPRVivoPower International PLC
      $ 0.8151
      (-39.62%)
      		2.3M
      IPWiPower Inc
      $ 0.7302
      (-39.15%)
      		1.13M
      CEROCERo Therapeutics Holdings Inc
      $ 0.2853
      (52.40%)
      		1.15B
      ELABElevai Labs Inc
      $ 0.0211
      (-19.47%)
      		377.69M
      NVDANVIDIA Corporation
      $ 141.98
      (-3.26%)
      		244.07M
      SPPLSIMPPLE Ltd
      $ 1.2503
      (41.60%)
      		164.49M
      STISolidion Technology Inc
      $ 0.44
      (25.71%)
      		139.46M

      CVAC Discussion

      View Posts
      Monksdream Monksdream 2 months ago
      CVAC under $4
      👍️0
      tw0122 tw0122 6 months ago
      There is a cure again
      👍️0
      Monksdream Monksdream 7 months ago
      CVAC new 52 week low
      👍️0
      Monksdream Monksdream 7 months ago
      CVAC new 52 week low
      👍️0
      Monksdream Monksdream 8 months ago
      CVAC new 52 week low
      👍️0
      Monksdream Monksdream 9 months ago
      CVAC new 52 week low
      👍️0
      mick mick 10 months ago
      https://www.otcmarkets.com/stock/CVAC
      👍️0
      mick mick 11 months ago
      https://www.otcmarkets.com/stock/CVAC
      👍️0
      mick mick 1 year ago
      https://www.otcmarkets.com/stock/CVAC
      👍️0
      mick mick 1 year ago
      https://www.otcmarkets.com/stock/CVAC
      👍️0
      mick mick 1 year ago
      https://www.otcmarkets.com/stock/CVAC
      👍️0
      mick mick 1 year ago
      CVAC
      CureVac NV
      8.99
      0.09 (1.01%)
      Volume: 232,857
      Day Range: 8.73 - 9.15
      Last Trade Time: 6:30:54 PM EDT
      👍️0
      Mr. Pearson Mr. Pearson 1 year ago
      Big News coming soon... just be patient....
      👍️0
      mick mick 1 year ago
      CVAC
      CureVac NV
      10.98
      1.30 (13.43%)
      Volume: 464,848
      Day Range: 9.72 - 10.47
      Last Trade Time: 7:53:28 PM EDT
      👍️0
      mick mick 1 year ago
      CVAC
      CureVac NV
      10.98
      1.30 (13.43%)
      Volume: 464,848
      Day Range: 9.72 - 10.47
      Last Trade Time: 7:53:28 PM EDT
      👍️0
      mick mick 1 year ago
      CVAC
      CureVac NV
      10.98
      1.30 (13.43%)
      Volume: 464,848
      Day Range: 9.72 - 10.47
      Last Trade Time: 7:53:28 PM EDT
      👍️0
      mick mick 1 year ago
      CVAC
      CureVac NV
      12.23
      0.80 (7.00%)
      Volume: 2,433,695
      Day Range: 11.02 - 12.36
      Last Trade Time: 7:59:28 PM EDT
      👍️0
      mick mick 1 year ago
      CVAC
      CureVac NV
      12.23
      0.80 (7.00%)
      Volume: 2,433,695
      Day Range: 11.02 - 12.36
      Last Trade Time: 7:59:28 PM EDT
      👍️0
      mick mick 1 year ago
      CVAC
      CureVac NV
      9.15
      -0.28 (-2.97%)
      Volume: 373,244
      Day Range: 9.06 - 9.49
      Last Trade Time: 6:38:15 PM EDT
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      7.37
      0.05 (0.68%)
      Volume: 613,302
      Day Range: 7.28 - 7.40
      Last Trade Time: 7:50:44 PM EDT
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      7.79
      -0.11 (-1.39%)
      Volume: 227,150
      Day Range: 7.66 - 8.13
      Last Trade Time: 5:09:42 PM EDT
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      7.79
      -0.11 (-1.39%)
      Volume: 227,150
      Day Range: 7.66 - 8.13
      Last Trade Time: 5:09:42 PM EDT
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      7.79
      -0.11 (-1.39%)
      Volume: 227,150
      Day Range: 7.66 - 8.13
      Last Trade Time: 5:09:42 PM EDT
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      7.79
      -0.11 (-1.39%)
      Volume: 227,150
      Day Range: 7.66 - 8.13
      Last Trade Time: 5:09:42 PM EDT
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      8.50
      -0.16 (-1.85%)
      Volume: 641,450
      Day Range: 8.52 - 8.68
      Last Trade Time: 7:00:46 PM EST
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      11.06
      -0.62 (-5.31%)
      Volume: 537,147
      Day Range: 11.01 - 11.83
      Last Trade Time: 7:55:22 PM EST
      👍️0
      mick mick 2 years ago
      it is relative CureVac (CVAC) Receives a Buy from Berenberg Bank
      August 23 2022 - 09:55PM
      TipRanks
      Alert
      Print
      Share On Facebook
      In a report released yesterday, Zhiqiang Shu from Berenberg Bank maintained a Buy rating on CureVac (CVAC - Research Report), with a price target of $45.00. The company's shares closed yesterday at $11.32.Shu covers the Healthcare sector, focusing on stocks such as Alnylam Pharma, Arcus Biosciences, and Sutro Biopharma. According to TipRanks, Shu has an average return of -21.0% and a 23.78% success rate on recommended stocks. Currently, the analyst consensus on CureVac is a Moderate Buy with an average price target of $28.50, implying a 151.77% upside from current levels.
      https://www.tipranks.com/news/blurbs/curevac-cvac-receives-a-buy-from-berenberg-bank?utm_source=advfn.com&utm_medium=referral
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      6.60
      -0.21 (-3.08%)
      Volume: 387,429
      Day Range: 6.58 - 6.99
      Last Trade Time: 4:09:13 PM EST
      👍️0
      mick mick 2 years ago
      i think $CVAC is ah buyout candidate /\

      let's say $40
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      6.81
      0.04 (0.59%)
      Volume: 1,065,479
      Day Range: 6.52 - 6.93
      Last Trade Time: 4:46:47 PM EST
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      7.49
      0.28 (3.88%)
      Volume: 181,787
      Day Range: 7.155 - 7.49
      Bid: 6.13
      Ask: 9.18
      Last Trade Time: 4:13:18 PM EDT
      Total Trades: 1,819
      CVAC Detailed Quote
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      7.49
      0.28 (3.88%)
      Volume: 181,787
      Day Range: 7.155 - 7.49
      Bid: 6.13
      Ask: 9.18
      Last Trade Time: 4:13:18 PM EDT
      Total Trades: 1,819
      CVAC Detailed Quote
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac N.V.
      Ordinary Shares
      9.84
      -0.40

      -3.90%

      Delayed (15 Min) Trade Data: 04:00pm 08/31/2022
      Overview
      Quote
      Company Profile
      Security Details
      News
      Financials
      Disclosure
      Research
      👍️0
      mick mick 2 years ago
      we don't show quote ?????
      👍️0
      mick mick 2 years ago
      we don't show quote ?????
      👍️0
      mick mick 2 years ago
      CureVac (CVAC) Receives a Buy from Berenberg Bank
      August 23 2022 - 09:55PM
      TipRanks
      Alert
      Print
      Share On Facebook
      In a report released yesterday, Zhiqiang Shu from Berenberg Bank maintained a Buy rating on CureVac (CVAC - Research Report), with a price target of $45.00. The company's shares closed yesterday at $11.32.Shu covers the Healthcare sector, focusing on stocks such as Alnylam Pharma, Arcus Biosciences, and Sutro Biopharma. According to TipRanks, Shu has an average return of -21.0% and a 23.78% success rate on recommended stocks. Currently, the analyst consensus on CureVac is a Moderate Buy with an average price target of $28.50, implying a 151.77% upside from current levels.
      https://www.tipranks.com/news/blurbs/curevac-cvac-receives-a-buy-from-berenberg-bank?utm_source=advfn.com&utm_medium=referral
      👍️0
      mick mick 2 years ago
      CVAC
      CureVac NV
      12.62
      -0.03 (-0.24%)
      Volume: 276,718
      Day Range: 12.39 - 12.79
      Bid: 12.60
      Ask: 13.18
      Last Trade Time: 4:57:18 PM EDT
      Total Trades: 3,775
      CVAC Detailed Quote
      👍️0
      sdy sdy 2 years ago
      Interesting new Beneficial Owners recently. Taken an entry position today.
      Looks like Covid-19 vaccines still hold prominent place in biotech research: "CureVac and GSK's second-generation vaccine candidate targeting two recent COVID-19 variants has been shown to be highly effective in preclinical studies on mice, CureVac said, as it seeks to catch up with rivals' development work." https://finance.yahoo.com/news/1-curevac-gsks-experimental-covid-124419805.html
      👍️0
      mick mick 2 years ago
      CureVac NV (CVAC)
      18.18 ? -0.65 (-3.45%)
      Volume: 402,327 @06/03/22 6:58:05 PM EDT
      Bid Ask Day's Range
      17.61 20.1 17.56 - 18.58
      CVAC Detailed Quote
      👍️0
      mick mick 2 years ago
      CureVac NV (CVAC)
      18.18 ? -0.65 (-3.45%)
      Volume: 402,327 @06/03/22 6:58:05 PM EDT
      Bid Ask Day's Range
      17.61 20.1 17.56 - 18.58
      CVAC Detailed Quote
      👍️0
      mick mick 3 years ago
      https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-contrafect-cfrx-curevac-cvac?utm_source=advfn.com&utm_medium=referral
      👍️0
      mick mick 3 years ago
      https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-contrafect-cfrx-curevac-cvac?utm_source=advfn.com&utm_medium=referral
      👍️0
      mick mick 3 years ago
      CureVac NV (CVAC)
      17.205 ? 0.625 (3.77%)
      Volume: 164,845 @04/29/22 1:27:43 PM EDT
      Bid Ask Day's Range
      17.2 17.25 16.47 - 17.44
      CVAC Detailed Quote
      👍️0
      mick mick 3 years ago
      CureVac NV (CVAC)
      15.69 ? -1.08 (-6.44%)
      Volume: 305,719 @03/11/22 5:11:50 PM EST
      Bid Ask Day's Range
      15.7 16.66 15.68 - 17.225
      CVAC Detailed Quote
      👍️0
      mick mick 3 years ago
      CureVac NV (CVAC)
      18.19 ? 0.05 (0.28%)
      Volume: 587,579 @02/04/22 5:09:58 PM EST
      Bid Ask Day's Range
      17.05 19.74 17.7685 - 18.61
      CVAC Detailed Quote
      👍️0
      mick mick 3 years ago
      https://www.otcmarkets.com/stock/CVAC
      👍️0
      mick mick 3 years ago
      https://www.otcmarkets.com/stock/CVAC
      👍️0
      2times2 2times2 3 years ago
      CureVac Says Preclinical Trial Shows Antibody Levels of COVID-19 Vaccine Candidate CV2CoV 'Highly Comparable' With Pfizer's mRNA Vaccine
      MT NEWSWIRES 3:11 PM ET 11/18/2021

      03:11 PM EST, 11/18/2021 (MT Newswires) -- CureVac(CVAC) said Thursday the extended preclinical study of the second-generation vaccine candidate, CV2CoV, showed that neutralizing antibody levels after full vaccination of animals were "highly comparable" with Pfizer (PFE) and BioNTech's (BNTX) licensed mRNA vaccine, Comirnaty.

      CureVac (CVAC) is developing CV2CoV in partnership with GlaxoSmithKline (GSK). Animals were vaccinated with either 12 micrograms of CV2CoV or a 30 microgram standard dose of Comirnaty.

      Data showed that targeted optimizations of a non-chemically modified mRNA can significantly improve immune responses in a preclinical model.

      👍️0
      mick mick 3 years ago
      CureVac NV (CVAC)
      38.0 ? -3.47 (-8.37%)
      Volume: 1,621,942 @11/05/21 7:55:54 PM EDT
      Bid Ask Day's Range
      38.02 38.19 36.32 - 39.33
      CVAC Detailed Quote
      👍️0
      mick mick 3 years ago
      CureVac NV (CVAC)
      38.64 ? -2.83 (-6.82%)
      Volume: 1,620,537 @11/05/21 4:05:48 PM EDT
      Bid Ask Day's Range
      38.0 38.2 36.32 - 39.33
      CVAC Detailed Quote
      👍️0

      Your Recent History

      NASDAQ
      CVAC
      CureVac NV
      BOV
      A1GN34
      Allegion
      Delayed Upgrade Clock